Rise and shine, everyone, another busy day is on the way. Already, the Pharmalot campus has been bustling, as our short person dashed for a ride to the local schoolhouse and the official mascots have been busy chasing assorted creatures on the leafy grounds. As for us, yes, we have the coffee kettle boiling once again. Now, though, the time has come to get still busier. On that note, here are some tidbits. Have a lovely day and do keep in touch …

The U.S. Department of Defense — and not the Food and Drug Administration — would have the power to approve drugs and medical devices under a defense policy bill being hammered out by a conference committee, Politico reports. And the legislation is alarming congressional staff and officials at the Department of Health and Human Services, who say it would undermine medical safety and potentially put soldiers at risk.

Unlock this article by subscribing to STAT Plus. Try it FREE for 30 days!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy